P379Safety of uninterrupted periprocedural edoxaban versus phenprocoumon for patients undergoing left atrial catheter ablation procedures

Autor:	Felix Berger, Verena Semmler, H Pausch, S. Lengauer, Tilko Reents, Isabel Deisenhofer, S. Brooks, Felix Bourier, M. Kornmayer, E. Rousseva, Gabriele Hessling, Marc Kottmaier, M. Telishevska, C. Kolb, K. Koch-Buettner
Rok vydání:	2018
Předmět:	medicine.medical_specialty business.industry medicine.medical_treatment Catheter ablation Phenprocoumon chemistry.chemical_compound chemistry Left atrial Edoxaban Physiology (medical) Internal medicine Cardiology Medicine Cardiology and Cardiovascular Medicine business medicine.drug
Zdroj:	EP Europace. 20:i67-i67
ISSN:	1532-2092 1099-5129
DOI:	10.1093/europace/euy015.190
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::78f67ca90ced8f26642a7ecb1926822e https://doi.org/10.1093/europace/euy015.190 Zobrazit plný text záznamu